Browsing OSU - Center for Health Sciences by Subject "opioid"
Now showing items 1-2 of 2
-
Protective effects of β-Funaltrexamine against LPS-induced CCL2 expression and behavioral deficits
(Oklahoma State University Center for Health Sciences, 2023-02-17)Background: Inflammation is present in both neurological and peripheral disorders. Specifically, inflammation is one of the common factors in diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), mood disorders ... -
β-Funaltrexamine protects against lipopolysaccharide-induced neuroinflammation and behavioral impairment
(Oklahoma State University Center for Health Sciences, 2022-02-18)Background: One of the commonalities present in a multitude of neurological disorders is inflammation. For this reason, targeting inflammation has emerged as a viable option for the potential treatment of neurological ...